- Home
- OPRX vs FBLG Comparison
OPRX vs FBLG Comparison
Compare OPRX & FBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPRX
- FBLG
- Stock Information
- Founded
- OPRX 2006
- FBLG 2021
- Country
- OPRX United States
- FBLG United States
- Employees
- OPRX N/A
- FBLG N/A
- Industry
- OPRX Business Services
- FBLG
- Sector
- OPRX Consumer Discretionary
- FBLG
- Exchange
- OPRX Nasdaq
- FBLG NYSE
- Market Cap
- OPRX 149.5M
- FBLG 163.3M
- IPO Year
- OPRX N/A
- FBLG 2024
- Fundamental
- Price
- OPRX $7.54
- FBLG $2.75
- Analyst Decision
- OPRX Buy
- FBLG Strong Buy
- Analyst Count
- OPRX 4
- FBLG 2
- Target Price
- OPRX $13.50
- FBLG $14.00
- AVG Volume (30 Days)
- OPRX 116.5K
- FBLG 881.3K
- Earning Date
- OPRX 11-04-2024
- FBLG 11-02-2024
- Dividend Yield
- OPRX N/A
- FBLG N/A
- EPS Growth
- OPRX N/A
- FBLG N/A
- EPS
- OPRX N/A
- FBLG N/A
- Revenue
- OPRX $83,202,506.00
- FBLG N/A
- Revenue This Year
- OPRX $43.61
- FBLG N/A
- Revenue Next Year
- OPRX $12.92
- FBLG N/A
- P/E Ratio
- OPRX N/A
- FBLG N/A
- Revenue Growth
- OPRX 35.15
- FBLG N/A
- 52 Week Low
- OPRX $6.84
- FBLG $1.08
- 52 Week High
- OPRX $16.65
- FBLG $46.00
- Technical
- Relative Strength Index (RSI)
- OPRX 45.38
- FBLG 47.17
- Support Level
- OPRX $6.84
- FBLG $2.58
- Resistance Level
- OPRX $7.94
- FBLG $3.27
- Average True Range (ATR)
- OPRX 0.42
- FBLG 0.37
- MACD
- OPRX 0.05
- FBLG -0.04
- Stochastic Oscillator
- OPRX 50.72
- FBLG 18.78
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
About FBLG FIBROBIOLOGICS INC
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.